NIH Funding Opportunities (Notices, PA, RFA)
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 36 min ago
Notice to Extend PA-20-028, Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18)
Notice NOT-HS-22-024 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-22-052 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), NCI, NIDA, and NCCIH invite Cooperative Agreement (U01) applications that propose prospective research studies to assess the benefits and harms of cannabis and cannabinoid use among adult cancer patients during active treatment. NCI, NIDA, and NCCIH are seeking well-designed prospective cohort studies of cancer patients with solid or hematologic tumors currently receiving treatment. Studies are expected to compare cancer patients who use cannabis/cannabinoids with cancer patients that do not use cannabis and/or cannabinoids. Research studies including diverse populations by age, sex, race/ethnicity, tumor types, and/or geography and propose population-based recruitment strategies using cancer registries are strongly encouraged. This FOA is published in parallel with RFA-CA-22-053 "Coordinating Center for Cannabis and Cannabinoid Use in Adult Cancer Patients During Treatment: Assessing Benefits and Harms (U24 Clinical Trial Not Allowed). New prospective studies and the coordinating center funded under these FOAs will work together with NIH program staff.
Categories: Job Watch, Literature Watch
Special Reminder: AHRQ Natural Disaster Policy - Hurricane Ian
Notice NOT-HS-22-025 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction to Application and Submission Information for RFA-NS-22-031 "Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24 Clinical Trial Not Allowed)"
Notice NOT-NS-23-028 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Research Misconduct and Detrimental Research Practices: An Overview and Case Studies Virtual Event on October 14, 2022
Notice NOT-OD-22-224 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Informational Webinar for PAR-22-180 "Maximizing Investigators' Research Award (MIRA)"
Notice NOT-GM-22-046 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Information: NCCIH Teaming Activity for Virtual Resource Centers for Research Across Complementary and Integrative Health Institutions (REACH) RFA-AT-23-007 (U24 Clinical Trial Not Allowed)
Notice NOT-AT-22-033 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Reminder: Annual Reports to the Office of Laboratory Animal Welfare due December 1, 2022
Notice NOT-OD-23-004 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program T32/TL1 Institutional Training Program as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
Notice NOT-OD-22-191 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to Key Dates and Eligibility Information in PAR-21-037, Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
Notice NOT-AI-22-065 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Pre-Application Webinar for Funding Opportunities to Extend and Expand the ECHO Cohort
Notice NOT-OD-23-001 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): HEAL Initiative: Grand Opportunity in Medications Development for Substance-Use Disorders
Notice NOT-DA-23-009 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Pre-Application Technical Assistance Webinar for NIDA RFA-DA-23-057 and RFA-DA-23-058
Notice NOT-DA-22-080 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required)
Notice NOT-CA-22-131 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)
Notice NOT-CA-22-130 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Pre-Application Webinar for the NHGRI Genomic Data Science Analysis, Visualization, and Informatics Lab-space Clinical Resource (ACR) (U24 Clinical Trial Not Allowed) (RFA-HG-22-021)
Notice NOT-HG-23-003 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
Notice NOT-CA-22-129 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to PAR-22-162, "Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
Notice NOT-CA-22-134 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to PAR-22-161, "Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
Notice NOT-CA-22-133 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): HEAL Initiative: Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose
Notice NOT-DA-23-010 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch